From: Compartmentalization and transporter engineering strategies for terpenoid synthesis
Organelle | Yeast species | Products | Titer or yield | Major engineering strategies | References |
---|---|---|---|---|---|
Endoplasmic reticulum | S. cerevisiae | β-amyrin | N.A. | Knock out PAH1 | [33] |
 |  | Aedicagenic-28-O-glucoside | 27.1 mg/L | Knock out PAH1 | [33] |
 |  | Artemisinic acid | N.A. | Knock out PAH1 | [33] |
 |  | Squalene | 634 mg/L | Overexpression of INO2 | [35] |
 |  | Ginsenoside | 12.1 mg/L | Overexpression of INO2 | [35] |
Lipid droplet | Y. Lipolytica | Lycopene | 16 mg/g | Strengthen the isoprenoid biosynthesis pathway and block the β-oxidation pathway | [47] |
 |  | Squalene | 731.18 mg/L | Co-overexpression of tHMG1 and DGA1 | [53] |
 | S. cerevisiae | Squalene | 445.6 mg/L | Co-overexpression of tHMG1 and DGA1 | [54] |
 |  | Lycopene | 2.37 g/L (73.3 mg/g) | Strengthen the TAG pathway and modulate TAG fatty acyl composition | [49] |
 |  | Ginsenoside | 5 g/L | Target protopanaxadiol synthase to LDs and strengthen the TAG pathway | [44] |
 |  | α-amyrin | 1107.9 mg/L | Semi-rational design of MdOSC1, strengthen the MVA pathway and overexpress DGA1 | [48] |
Peroxisome | P. pastoris | Lycopene | 73.9Â mg/L | Target heterologous carotenogenic enzymes to peroxisomes | [74] |
 |  | α-humulene | 3.2 g/L | Introduce the α-humulene synthesis pathway to peroxisomes | [77] |
 | S. cerevisiae | Squalene | 11 g/L | Hybridization of the cytoplasm- and peroxisome-engineered strain | [63] |
 |  | Geraniol | 2.75 mg/L | Deletion of PEX30 and PEX32 and introduce the geraniol synthesis pathway into peroxisomes | [72] |
 |  |  | 5.5 g/L | Introduce a complete MVA pathway in peroxisomes | [75] |
 |  | (R)-(+)-limonene | 2.6 g/L | Introduce a complete MVA pathway in peroxisomes | [75] |
 |  | Protopanaxadiol | N.A. | Knock out PEX11, PEX34, and ATG36 | [73] |
 |  | α-humulene | 1726.78 mg/L | Introduce the α-humulene biosynthesis pathway into peroxisomes and block the expression of ERG9 | [76] |
 |  | β-Amyrin | 2.6 g/L | Introduce the MVA pathway into peroxisomes | [78] |
Mitochondrion | S. cerevisiae | Valencene | 1.5Â mg/L | Co-overexpression of tHMG1, mitochondrion-targeted heterologous FDP synthase and amorphadiene synthase | [84] |
 |  | Amorphadiene | 20 mg/L | Co-overexpression of tHMG1, mitochondrion-targeted heterologous FDP synthase and amorphadiene synthase | [84] |
 |  | Amorpha-4,11-diene | 427 mg/L | Introduce the amorpha-4,11-diene biosynthesis pathway to mitochondria | [86] |
 |  | Linalool | 21 mg/L | Dual mevalonate pathways in mitochondria and cytoplasm | [88] |
 |  | Geraniol | 43.3 mg/L | Introduce the geraniol biosynthetic pathway into mitochondria | [89] |
 |  | Patchoulol | 19.24 mg/L | Introduce the DMAPP pathway into mitochondria | [90] |
 |  | Isoprene | 2527 mg/L | Introduce the complete MVA pathway together with isoprene synthase (ISPS) into mitochondria | [91] |
 |  |  | 11.9 g/L | Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization | [92] |
Plasma membrane | S. cerevisiae | β-Ionone | 184 mg/L (32 mg/g) | Target the β-carotene cleavage dioxygenase to the membrane | [95] |
 | E. coli | Astaxanthin | N.A. | Target CrtW and CrtZ to the membrane via a GlpF protein | [94] |
 |  | Squalene | 612 mg/L | Overexpression of TSR to expand membrane volume | [93] |
 |  | β-carotene | 44.2 mg/g DCW | Overexpression of ALMGS and PLSB/PLSC to increase membrane surface area and enhance membrane synthesis | [24] |